In the United States, roughly 12 percent of drugs that enter clinical testing ultimately receive approval … Why Drugs Fail After Phase I in the U.S. MarketRead more
Phase I clinical trials
Why So Many Pharma Companies Get Stuck in Phase I Clinical Trials
In the United States, drug development rarely collapses at the finish line. It slows, fragments, and … Why So Many Pharma Companies Get Stuck in Phase I Clinical TrialsRead more